KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 63 filers reported holding KINNATE BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,809,963 | +495.7% | 1,089,594 | +481.4% | 0.09% | +520.0% |
| Q4 2022 | $1,143,128 | -81.8% | 187,398 | -64.3% | 0.02% | -83.0% |
| Q3 2022 | $6,270,000 | +91.0% | 524,669 | +101.6% | 0.09% | +72.5% |
| Q2 2022 | $3,282,000 | +12.0% | 260,276 | 0.0% | 0.05% | +6.2% |
| Q1 2022 | $2,931,000 | -36.4% | 260,276 | 0.0% | 0.05% | -27.3% |
| Q4 2021 | $4,612,000 | -23.0% | 260,276 | 0.0% | 0.07% | -32.7% |
| Q3 2021 | $5,992,000 | -1.1% | 260,276 | 0.0% | 0.10% | -13.3% |
| Q2 2021 | $6,059,000 | -32.0% | 260,276 | -9.0% | 0.11% | -42.9% |
| Q1 2021 | $8,916,000 | -18.9% | 286,129 | +3.5% | 0.20% | -32.2% |
| Q4 2020 | $10,997,000 | – | 276,451 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 9,671,643 | $384,738,000 | 41.79% |
| Foresite Capital Management V, LLC | 875,001 | $34,808,000 | 25.78% |
| Vida Ventures Advisors, LLC | 2,747,074 | $109,279,000 | 22.43% |
| VR Adviser, LLC | 1,473,014 | $58,596,000 | 8.62% |
| RA Capital Management | 3,593,052 | $142,932,000 | 2.00% |
| Logos Global Management LP | 569,602 | $22,659,000 | 1.94% |
| Boxer Capital, LLC | 1,064,665 | $42,352,000 | 1.36% |
| Orbimed Advisors | 3,847,929 | $153,071,000 | 1.34% |
| HARVARD MANAGEMENT CO INC | 498,001 | $19,810,000 | 1.07% |
| DAFNA Capital Management LLC | 68,121 | $2,710,000 | 0.81% |